Sergliflozin Etabonate — CAS 125926-17-2

Sergliflozin Etabonate is a prodrug of the selective sodium-glucose cotransporter 2 (SGLT2) inhibitor Sergliflozin. By inhibiting SGLT2 in the kidneys, it reduces reabsorption of glucose and promotes urinary glucose excretion, thereby lowering blood glucose levels in type 2 diabetes. Mediocon Inc supplies high-purity Sergliflozin Etabonate API from its GMP-certified manufacturing plant in Aurangabad, Maharashtra.

• Type 2 Diabetes Mellitus
• SGLT2 inhibition
• Urinary glucose excretion promotion
• Glycemic control

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support